![]() Tanvex BioPharma Tanvex BioPharma (formerly known as Ruenvex Biotech) is a company that manufactures and develops biosimilar and biologic products and drugs. | ![]() Juno Therapeutics Juno Therapeutics is a clinical-stage company, which develops immunotherapies for the treatment of cancer. | ![]() Tetraphase Pharmaceuticals Tetraphase Pharmaceuticals is a company leveraging a dynamic drug engine targeted at several significant disease categories. | ![]() centrose centrose is a biotechnology company engaged in the development and commercialization of antibody drug conjugates (ADCs), targeting disease-related cells. | |||
Founding Date | Founding Date 2011 | Founding Date 2013 | Founding Date 1992 | Founding Date 2013 | Founding Date 2006 | Founding Date 2007 |
Type | Type Subsidiary | Type Public | Type Public | Type Subsidiary | Type Subsidiary | Type Private |
Tags | ||||||
Locations | Locations Cambridge, US HQ | Locations Taipei, TW HQ New Taipei, TW Irvine, US San Diego, US San Diego, US | Locations Somerville, US HQ | Locations Seattle, US HQ Göttingen, DE Göttingen, DE München, DE München, DE Bothell, US Brisbane, US | Locations Watertown, US HQ Waltham, US | Locations Middleton, US HQ |
Employees | Employees 378% decrease | Employees 13628% decrease | Employees 32338% decrease | Employees 1182% decrease | Employees 14 | Employees N/A |
Financial | ||||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) NT$61.4m (FY, 2023) | Revenue (est.) $3.6m (FY, 2022) | Revenue (est.) $111.9m (FY, 2017) | Revenue (est.) $7.4m (FY, 2019) | Revenue (est.) N/A |
Net income | Net income N/A | Net income (NT$2.1b) (FY, 2023) | Net income ($266.6m) (FY, 2022) | Net income ($437.1m) (FY, 2017) | Net income ($70.1m) (FY, 2019) | Net income N/A |
Funding | ||||||
Total funding raised | Total funding raised $ 200m | Total funding raised $ 346.9m | Total funding raised $ 409m | Total funding raised $ 310m | Total funding raised $ 94.8m | Total funding raised $ 100k |
Tanvex BioPharma (formerly known as Ruenvex Biotech) is a company that manufactures and develops biosimilar and biologic products and drugs.
View companyBluebird Bio is a developer of gene therapies for severe genetic diseases.
View companyJuno Therapeutics is a clinical-stage company, which develops immunotherapies for the treatment of cancer.
View companyTetraphase Pharmaceuticals is a company leveraging a dynamic drug engine targeted at several significant disease categories.
View company